Accueil   Diary - News   All news AAA Reports 37% growth in sales for the 3th quarter of 2015

AAA Reports 37% growth in sales for the 3th quarter of 2015

  • Reported an increase in year -over-year sales of approximately 37% for Q3 2015 compared toQ3 2014

 

  • Reported an increase in year-over-year sales of approximately 32% for the first nine months of 2015 compared to the first nine months of 2014

 

 

  • Announced positive results from Phase 3 NETTER-1 study, evaluating lead drug candidate Lutathera in patients with advanced midgut neuroendocrine tumors

 

  • Obtained two Marketing Authorizations in France for FCholine and FDopa

 

  • Received FDA Priority Review for Somakit-TATE New Drug Application

 

  • Submitted MA application to EMA for Somakit-TOC

 

 

 

Read the press release

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree